188 related articles for article (PubMed ID: 20819953)
1. Regulation of cAMP-dependent protein kinases: the human protein kinase X (PrKX) reveals the role of the catalytic subunit alphaH-alphaI loop.
Diskar M; Zenn HM; Kaupisch A; Kaufholz M; Brockmeyer S; Sohmen D; Berrera M; Zaccolo M; Boshart M; Herberg FW; Prinz A
J Biol Chem; 2010 Nov; 285(46):35910-8. PubMed ID: 20819953
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis for isoform-specific autoregulation of protein kinase A.
Diskar M; Zenn HM; Kaupisch A; Prinz A; Herberg FW
Cell Signal; 2007 Oct; 19(10):2024-34. PubMed ID: 17614255
[TBL] [Abstract][Full Text] [Related]
3. Two PKA RIα holoenzyme states define ATP as an isoform-specific orthosteric inhibitor that competes with the allosteric activator, cAMP.
Lu TW; Wu J; Aoto PC; Weng JH; Ahuja LG; Sun N; Cheng CY; Zhang P; Taylor SS
Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16347-16356. PubMed ID: 31363049
[TBL] [Abstract][Full Text] [Related]
4. PrKX is a novel catalytic subunit of the cAMP-dependent protein kinase regulated by the regulatory subunit type I.
Zimmermann B; Chiorini JA; Ma Y; Kotin RM; Herberg FW
J Biol Chem; 1999 Feb; 274(9):5370-8. PubMed ID: 10026146
[TBL] [Abstract][Full Text] [Related]
5. PKA catalytic subunit mutations in adrenocortical Cushing's adenoma impair association with the regulatory subunit.
Calebiro D; Hannawacker A; Lyga S; Bathon K; Zabel U; Ronchi C; Beuschlein F; Reincke M; Lorenz K; Allolio B; Kisker C; Fassnacht M; Lohse MJ
Nat Commun; 2014 Dec; 5():5680. PubMed ID: 25477193
[TBL] [Abstract][Full Text] [Related]
6. cAMP-dependent protein kinase regulatory subunit type IIbeta: active site mutations define an isoform-specific network for allosteric signaling by cAMP.
Zawadzki KM; Taylor SS
J Biol Chem; 2004 Feb; 279(8):7029-36. PubMed ID: 14625280
[TBL] [Abstract][Full Text] [Related]
7. The roles of the RIIβ linker and N-terminal cyclic nucleotide-binding domain in determining the unique structures of the type IIβ protein kinase A: a small angle x-ray and neutron scattering study.
Blumenthal DK; Copps J; Smith-Nguyen EV; Zhang P; Heller WT; Taylor SS
J Biol Chem; 2014 Oct; 289(41):28505-12. PubMed ID: 25112875
[TBL] [Abstract][Full Text] [Related]
8. An Isoform-Specific Myristylation Switch Targets Type II PKA Holoenzymes to Membranes.
Zhang P; Ye F; Bastidas AC; Kornev AP; Wu J; Ginsberg MH; Taylor SS
Structure; 2015 Sep; 23(9):1563-1572. PubMed ID: 26278174
[TBL] [Abstract][Full Text] [Related]
9. Probing cAMP-dependent protein kinase holoenzyme complexes I alpha and II beta by FT-IR and chemical protein footprinting.
Yu S; Mei FC; Lee JC; Cheng X
Biochemistry; 2004 Feb; 43(7):1908-20. PubMed ID: 14967031
[TBL] [Abstract][Full Text] [Related]
10. Structural analyses of the PKA RIIβ holoenzyme containing the oncogenic DnaJB1-PKAc fusion protein reveal protomer asymmetry and fusion-induced allosteric perturbations in fibrolamellar hepatocellular carcinoma.
Lu TW; Aoto PC; Weng JH; Nielsen C; Cash JN; Hall J; Zhang P; Simon SM; Cianfrocco MA; Taylor SS
PLoS Biol; 2020 Dec; 18(12):e3001018. PubMed ID: 33370777
[TBL] [Abstract][Full Text] [Related]
11. Novel isoform-specific interfaces revealed by PKA RIIbeta holoenzyme structures.
Brown SH; Wu J; Kim C; Alberto K; Taylor SS
J Mol Biol; 2009 Nov; 393(5):1070-82. PubMed ID: 19748511
[TBL] [Abstract][Full Text] [Related]
12. Isoform specific differences in binding of a dual-specificity A-kinase anchoring protein to type I and type II regulatory subunits of PKA.
Burns LL; Canaves JM; Pennypacker JK; Blumenthal DK; Taylor SS
Biochemistry; 2003 May; 42(19):5754-63. PubMed ID: 12741833
[TBL] [Abstract][Full Text] [Related]
13. Characterization of in-vitro-translated human regulatory and catalytic subunits of cAMP-dependent protein kinases.
Foss KB; Landmark B; Skålhegg BS; Taskén K; Jellum E; Hansson V; Jahnsen T
Eur J Biochem; 1994 Feb; 220(1):217-23. PubMed ID: 8119290
[TBL] [Abstract][Full Text] [Related]
14. The differential response of protein kinase A to cyclic AMP in discrete brain areas correlates with the abundance of regulatory subunit II.
Ventra C; Porcellini A; Feliciello A; Gallo A; Paolillo M; Mele E; Avvedimento VE; Schettini G
J Neurochem; 1996 Apr; 66(4):1752-61. PubMed ID: 8627334
[TBL] [Abstract][Full Text] [Related]
15. Compensatory stabilization of RIIbeta protein, cell cycle deregulation, and growth arrest in colon and prostate carcinoma cells by antisense-directed down-regulation of protein kinase A RIalpha protein.
Nesterova M; Noguchi K; Park YG; Lee YN; Cho-Chung YS
Clin Cancer Res; 2000 Sep; 6(9):3434-41. PubMed ID: 10999726
[TBL] [Abstract][Full Text] [Related]
16. PKA type IIalpha holoenzyme reveals a combinatorial strategy for isoform diversity.
Wu J; Brown SH; von Daake S; Taylor SS
Science; 2007 Oct; 318(5848):274-9. PubMed ID: 17932298
[TBL] [Abstract][Full Text] [Related]
17. Cyclic-AMP and pseudosubstrate effects on type-I A-kinase regulatory and catalytic subunit binding kinetics.
Anand G; Taylor SS; Johnson DA
Biochemistry; 2007 Aug; 46(32):9283-91. PubMed ID: 17658893
[TBL] [Abstract][Full Text] [Related]
18. Differential binding of cAMP-dependent protein kinase regulatory subunit isoforms Ialpha and IIbeta to the catalytic subunit.
Cheng X; Phelps C; Taylor SS
J Biol Chem; 2001 Feb; 276(6):4102-8. PubMed ID: 11110787
[TBL] [Abstract][Full Text] [Related]
19. R-subunit isoform specificity in protein kinase A: distinct features of protein interfaces in PKA types I and II by amide H/2H exchange mass spectrometry.
Anand GS; Hotchko M; Brown SH; Ten Eyck LF; Komives EA; Taylor SS
J Mol Biol; 2007 Nov; 374(2):487-99. PubMed ID: 17942118
[TBL] [Abstract][Full Text] [Related]
20. Mapping intersubunit interactions of the regulatory subunit (RIalpha) in the type I holoenzyme of protein kinase A by amide hydrogen/deuterium exchange mass spectrometry (DXMS).
Hamuro Y; Anand GS; Kim JS; Juliano C; Stranz DD; Taylor SS; Woods VL
J Mol Biol; 2004 Jul; 340(5):1185-96. PubMed ID: 15236976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
